The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Oct 2012 12:00

RNS Number : 1660O
Akers Biosciences, Inc.
08 October 2012
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Akers Biosciences

ISIN: USU009441051

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

x

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Commerzbank AG

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

4 October 2012

6. Date on which issuer notified:

5 October 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

USU009441051

8,728,500

8,728,500

8,728,500

8,728,500

3.51%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

n/a

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,728,500

3.51%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Lisa Carter

Compliance Dept

15. Contact telephone number:

020 7475 5225

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGGAUUPPGUR
Date   Source Headline
26th Nov 20099:28 amRNSHolding(s) in Company
25th Nov 20099:21 amRNSDirectorate Change
24th Nov 20097:00 amRNSHolding(s) in Company
4th Nov 20097:00 amRNSTrading Statement
30th Sep 20097:00 amRNSHalf Yearly Report
29th Sep 20097:00 amRNSABI Signs Malaria Test Distribution Agreement
13th Jul 20095:29 pmRNSResult of AGM
26th Jun 20099:19 amRNSAnnual Report & Accounts
25th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 20097:00 amRNSFinal Results
19th Mar 20093:26 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSNotice of Preliminary Results
8th Jan 20091:48 pmRNSGrant of Warrants - Replacement
8th Jan 200912:00 pmRNSGrant of Warrants
8th Jan 20097:00 amRNSTrading Update
5th Jan 20097:00 amRNSTechnology Transfer & Supply Agreement
3rd Dec 20087:00 amRNSABI Sells Tax Losses in State of NJ, USA
20th Nov 20087:00 amRNSU.S. Over-the-Counter Distribution Agreement
27th Oct 20087:00 amRNSDirectorate Change
16th Sep 20083:17 pmRNSDirector/PDMR Shareholding
8th Sep 20087:30 amRNSNew Diagnostics in Diabetes
8th Sep 20087:00 amRNSInterim Results
4th Aug 20087:00 amRNSNotice of First Half Results
14th Jul 20087:00 amRNSABI Licenses Lithium System
26th Jun 20087:00 amRNSABI Signs New Distribution Ag
12th Jun 20083:50 pmRNSPlacing Update
11th Jun 20087:00 amRNSAdditional Listing
4th Jun 20089:00 amRNSAnnual Report and Accounts
4th Jun 20087:00 amRNSOption Agreement
9th Apr 20087:00 amRNSDirector/PDMR Shareholding
7th Apr 20087:01 amRNSFinal Results
3rd Apr 20087:00 amRNSDirectorate Change
14th Mar 200811:31 amRNSIssue of Equity
14th Jan 200810:17 amRNSIssue of Equity
7th Jan 20084:20 pmRNSResolution of Litigation
20th Dec 20077:01 amRNSDirector/PDMR Shareholding
18th Dec 200712:01 pmRNSChange of Adviser
28th Sep 200710:41 amRNSTotal Voting Rights
28th Sep 20077:00 amPRNDirectors' Shareholdings & Additional Listing
27th Sep 20077:00 amPRNHalf-yearly Report
18th Sep 20077:00 amPRNUnited States Military Contract
17th Sep 20077:00 amPRNUnited States Military Contract
12th Sep 20077:00 amPRNUK Sales Agency Agreement
7th Sep 200712:52 pmRNSIssue of Equity
21st Aug 20075:07 pmRNSChange of Nominated Adviser
17th Aug 20072:04 pmRNSAIM Rule 26
9th Aug 20077:00 amPRNDirectorate Change
8th Aug 20076:24 pmPRNAGM Statement
2nd Aug 20077:00 amPRNNotice of Results
31st Jul 20079:22 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.